Des Moines, Laurel Street

411 Laurel Street Suite A300, Des Moines, IA 50314

Mission Cancer + Blood, part of UI Health Care, provides clinical services within MercyOne Cancer Center.

Des Moines, Laurel Street, exterior.

Location hours

  • Monday – Friday: 8:00am – 5:00pm
Clinic and amenities hours may vary.
See all clinic and amenities at this location.
1-515-282-2921

Driving directions and parking

411 Laurel Street Suite A300, Des Moines, IA 50314

41.5978199, -93.6231369

Turn-by-turn directions

Services at this location

Bile Duct Cancer
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer
Chemotherapy
Colorectal Cancer
Esophageal Cancer
Gallbladder Cancer
Gynecologic Cancer
Head and Neck Cancers
Immunotherapy
Kidney Cancer
Leukemia
Liver Cancer
Lymphoma
Melanoma
Multiple Myeloma
Neuroendocrine Cancer
Oncology Nutrition Services
Oncology Social Work
Ovarian Cancer
Pancreatic Cancer
Penile Cancer
Prostate Cancer
Sarcoma
Small Intestine Cancer
Stomach Cancer
Testicular Cancer
Thyroid Cancer
Show more

Clinics and amenities at this location

Select office type

Need help selecting a provider?

When you call 1-515-282-2921 we'll help you find a provider who meets your needs.
Call 1-515-282-2921

Clinical Trials

Mission Cancer + Blood offers a variety of cancer clinical trials at our Des Moines, Laurel Street location.

Browse sub-categories
Or

Patient Stories

Life on the other side of a diagnosis
October 21, 2026
Breast cancer survivor Meghan McConville shares how she felt seen, heard, and understood by her care team at Mission Cancer + Blood, part of Universit...
Moving forward with an open mind and an open heart
October 12, 2026
Two-time cancer survivor Paige Connolly discusses her experience receiving care at Mission Cancer + Blood, part of University of Iowa Health Care
Browse more patient stories

Related News

Browse More
Mission Cancer + Blood offers cutting-edge theranostic precision treatment for cancer patients
November 5, 2026
Bradley Hiatt, DO, speaking with colleagues in a clinical care setting at UI Health Care.
Mission Cancer + Blood and University of Iowa Health Care administer game-changing pancreatic cancer drug
July 28, 2026

Educational Resources

What to expect during cancer treatment
Thoughts for the caregiver/cook during cancer treatment
The complete blood count: A guide for patients with cancer
Taste changes during cancer treatment
Sore mouth during cancer treatment
Nausea and vomiting during cancer treatment
Loss of appetite or weight during cancer treatment
Gas and bloating during cancer treatment
Food safety during cancer treatment
Difficulty swallowing and chewing during cancer treatment
Diarrhea during cancer treatment
Constipation during cancer treatment
Dry mouth during cancer treatment

Awards and Recognition

U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
Learn more
U.S. News & World Report - No. 1 in Iowa for Cancer Care
We are proudly ranked No. 1 in Iowa for Cancer Care in the 2026–27 “Adult, Best Hospitals” report.
Learn more
U.S. News & World Report - Leukemia
In 2026-27 our leukemia program was identified as High Performing by U.S. News & World Report.
Learn more
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
Learn more
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
Learn more
U.S. News & World Report - Lymphoma
In 2026-27 our lymphoma program was identified as High Performing by U.S. News & World Report.
Learn more
U.S. News & World Report - Myeloma
In 2026-27 our myeloma program was identified as High Performing by U.S. News & World Report.
Learn more
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
Learn more